This study offers an answer to the long-standing question of how the tumor suppressor ARF inhibits ribosome biogenesis, which does not involve p53 but is essential to prevent Ras-induced cell transformation.
Introduction
The role of ARF in regulating p53 is well established, but the mechanisms by which it exerts its p53-independent tumor suppressor function have yet to be fully characterized. A common theme in ARF's p53-independent activity is its ability to regulate nucleolar ribosome biogenesis 11, 40 , but mechanistic details of its involvement have remained elusive. Understanding the p53-independent functions of ARF in the nucleolus is an increasingly important focus in cancer biology.
The nucleolus is a dynamic organelle that assembles around ribosomal DNA (rDNA)
repeats and is the cellular center for ribosome biogenesis. Characterization of the nucleolar proteome has revealed the broad spectrum of resident proteins (1) . As nucleoli lack membranes, proteins freely diffuse into and out of nucleoli in response to varying conditions (2) . Some of the most important residents of nucleoli are proteins that regulate ribosome production, including p19ARF (p14ARF in humans).
The canonical function of ARF is to activate p53 by binding and sequestering the p53 inhibitor Mdm2 (3) (4) (5) (6) . Arf-null mice develop spontaneous tumors consisting of predominantly fibrosarcomas and lymphomas (7, 8) . However, ARF also possesses p53-independent roles that contribute to its growth-inhibitory function and suppression of tumorigenesis (9) . For example, basal ARF maintains nucleolar structure and function (10) at least in part through its ability to interact with nucleophosmin (NPM) (11) (12) (13) (14) (15) . The ability of ARF to regulate the nucleolar localization of Mdm2 (4) and the nuclear export of nucleophosmin (14) suggests that ARF may monitor nucleolar function by regulating the composition of the nucleolar proteome. To determine how the presence or absence of basal ARF affects nucleolar protein composition, we conducted a proteomic screen using isolated nucleoli from wild type and Arf-/-mouse embryonic fibroblasts (MEFs). Among the proteins enriched in nucleoli in the absence of Arf was DDX5, a DEAD-box protein also known as p68 RNA helicase.
The DEAD-box family of RNA helicases is defined by a conserved Asp-Glu-Ala-Asp motif that interacts with Mg 2+ and is involved in ATP hydrolysis (16) . DEAD-box proteins also contain several conserved motifs that have been shown to function in ATP binding, ATPase activity, and helicase activity (17) . Many cellular functions of DEAD-box RNA helicases have been attributed to RNA duplex unwinding and ribonucleoprotein (RNP) complex remodeling (18) . In yeast, several RNA helicases have been demonstrated to facilitate ribosome biogenesis (19) , which involves both the processing of ribosomal RNA (rRNA) as well as its assembly into functional RNP complexes. Given that the cellular center for ribosome synthesis is the nucleolus, it is not surprising that many RNA helicases have been identified as components of the nucleolar proteome (1, 2).
The involvement of several known oncogenes and tumor suppressors in the regulation of protein synthesis underscores the importance of ribosomes and mRNA translational control in cancer (20) . Thus, the ability of ARF to direct balanced RNA metabolism in the nucleolus could provide insights into how this major cellular axis might impact tumorigenesis. Apart from its classical function as a sensor of hyperproliferative signals (21-23), we now show that ARF limits non-oncogene-driven ribosome biogenesis to inhibit cellular transformation.
Materials and Methods
Cell culture and Reagents. Primary mouse embryonic fibroblasts were isolated and cultured as described (14) . Rabbit anti-DDX5 (A300-523A) was purchased from Bethyl Laboratories.
Mouse anti-NPM (cat no. 32-5200) was purchased from Zymed. Rat anti-p19ARF (ab26696) was purchased from Abcam. H-Ras, p21, and Gamma-tubulin antibodies were purchased from Santa Cruz Biotechnology.
Nucleolar Isolation. Nucleoli were isolated from 2x10 8 cells, essentially as described by
Andersen and colleagues (1) . Additional details for the nucleolar isolation protocol are included with the supplementary material.
Proteomic Analysis. Gel preparation, analysis and mass spectrometry were performed as previously described (24) . Wild type nucleolar isolates were labeled with Cy3 and Arf-/-nucleolar isolates were labeled with Cy5. Samples were mixed and subjected to 2D SDS-PAGE.
First-dimension isoelectric focusing was performed on immobilized pH gradient strips in an Ettan IPGphor system (GE Healthcare). Second dimension separation was performed on 10% isocratic SDS/PAGE gels (20 x 24cm). Imaging was performed using a Typhoon 9400 scanner (GE Healthcare) and Decyder DIA and BVA software (GE Healthcare) was used to quantify matched gel spots. Spots demonstrating >2-fold differences in intensity were isolated and identified by MALDI-TOF/TOF mass spectrometry.
Immunofluorescence. Cells were fixed with 4% paraformaldeyde in PBS for 10 minutes. Cells were permeabilized with 1% NP-40, blocked in 5% FBS, and stained with rabbit anti-DDX5 and mouse anti-NPM , followed by FITC-conjugated anti-mouse and RhodamineX-conjugated antirabbit (both from Jackson Immunoresearch). Samples were counterstained with DAPI and mounted with Vectashield (Vector Labs). Four independent MEF isolates were used to assess localization of DDX5. Images were acquired using a 100X oil immersion lens on a Zeiss LSM5 Pascal Vario Two UGB coupled to Axiovert 200 confocal microscope.
Quantitative real-time PCR. Total RNA was isolated from WT and Arf -/-MEFs using Illustra RNAspin columns (GE Healthcare) according to manufacturer's protocol. First strand cDNA synthesis and real-time PCR were as previously described (25 Cells were harvested, lysed, and subjected to immunoprecipitation and RNA extraction as previously described (25) .
Ribosome Fractionation. Cells were treated with cycloheximide, collected, and fractionated by sucrose gradient centrifugation as previously described (25) . Total protein was precipitated from individual fractions with trichloroacetic acid and analyzed by western blot.
Foci formation and proliferation assays. MEFs were plated in triplicate at the indicated concentrations and foci formation and proliferation assays were conducted as previously described (26) .
Soft agar.
Arf-/-MEFs were infected with shRNAs against luciferase or DDX5, prior to infection with either Ras V12 or empty vector (pBabe). Cells were seeded onto soft agar at 10 4 cells per 6 cm 2 dish and grown for 3 weeks. Cells were re-layered with soft agar on a weekly basis and visible colonies were counted after 3 weeks.
Tumorigenesis Assay. Arf-/-MEFs were infected with RasV12 and either shDDX5 or shSCR.
Fibroblasts were trypsinized and resuspended in PBS at a concentration of 2x10 7 cells/mL. (Fig. 1B) , and were free of nucleoplasmic contaminants (Fig. 1C) .
Nucleolar isolates were subjected to comparative two dimensional differential gel electrophoresis (2D-DIGE) proteomic analysis. Twenty-six spots which showed differences greater than 2.5 standard deviations from the mean change were excised, and 19 were positively identified by mass spectroscopy (Supplementary Table 1 ). Among the differences between wild type and Arf-/-MEFs, enhanced nucleolar expression (10-fold) of DDX5 RNA helicase was observed in the absence of Arf (Fig. 1D ). Immunofluorescence revealed enhanced nucleolar co-localization of DDX5 with NPM in Arf-/-MEFs (Fig. 1E ). Biochemical fractionation confirmed the increased presence of DDX5 in Arf-/-nucleoli relative to wild-type nucleoli (Fig. 1F ).
To investigate whether nucleolar exclusion of DDX5 is mediated by ARF through its activation of p53, we treated Arf-/-MEFs with nutlin-3, a pharmacological inhibitor of Mdm2.
Instead of stimulating DDX5 nucleolar exclusion, nucleolar localization of DDX5 persisted in the presence of nutlin-3 ( Fig. S1 ). This demonstrates that p53 activation is not responsible for the ARF-dependent nucleolar exclusion of DDX5 observed in wild type MEFs, consistent with a p53-independent role for ARF in regulating DDX5 localization. The nucleolar localization of DDX5, along with its function as an RNA helicase, suggested that DDX5 might be involved in the biogenesis of rRNA. The regulation of DDX5 localization by basal ARF led us to investigate whether ARF could control ribosome biogenesis through regulation of DDX5 function. Both p19ARF (mouse) and p14ARF (human) inhibit rRNA transcription (10, 27, 28) , and DDX5 has been ascribed roles as a transcriptional regulator (17) . However, it is unknown whether DDX5 regulates transcription at nucleolar rDNA loci.
We conducted chromatin immunoprecipitation experiments to determine whether DDX5 associated with the rDNA promoter at two previously identified binding sites of the RNA polymerase I transcription factor UBF (29) . ARF regulated DDX5 association with these sites, such that DDX5 occupancy at the rDNA promoter was over two-fold greater in Arf-/-MEFs compared to wild-type MEFs ( Fig. 2A) .
Additionally, DDX5 has been shown to be involved in processing of the 5.8S rRNA (30) and the 28S rRNA from their respective rRNA precursors (31) . By immunoprecipitation, we observed an interaction between DDX5 and the 28S and 18S rRNA species (Fig. 2B ). This association with mature rRNA suggests that DDX5 could be involved at multiple stages in the production and assembly of ribosomes. In wild-type MEFs the interaction of DDX5 with rRNA was decreased relative to Arf-/-cells, suggesting that ARF can inhibit this association as well.
We hypothesized that ARF may interfere with the ability of DDX5 to stimulate ribosome biogenesis by impeding access of DDX5 to maturing pre-ribosomes. Nuclear lysates obtained from wild-type and Arf-/-MEFs were separated by sucrose gradient centrifugation. Enhanced association of DDX5 with the 40S and 60S pre-ribosomal fractions was observed in the Arf-/-nuclear lysates relative to the corresponding wild-type fractions (Fig. 2D) . These changes were not due to altered expression since wild-type and Arf-/-MEFs expressed similar levels of DDX5 protein in both whole cell lysate ( Fig. 1F ) and nuclear extract (Fig. 2C) .
DDX5 enhances the synthesis and processing of ribosomal RNA.
In order to determine whether DDX5 could accelerate ribosome biogenesis, wild-type MEFs were transduced with a Flag-epitope-tagged DDX5 or a mutant (K144N) deficient in ATP binding (Fig. 3A) . The K144N mutation in the Walker A motif abrogates not only ATP binding, but also the ATPase and helicase activities of DDX5 (31) . The earliest observed effect of DDX5 on ribosome biogenesis was at the level of 47S pre-rRNA transcription, where both Flag-DDX5
and Flag-DDX5-K144N increased the amount of 47S transcript per cell (Fig. 3B) . The ability of DDX5 to regulate transcription of 47S pre-RNA concurred with its aforementioned association at the rDNA promoter. Monitoring the processing of the 47S pre-rRNA transcript by pulse-chase analysis, we discovered a more rapid accumulation of mature 28S and 18S rRNAs in cells expressing Flag-DDX5 or Flag-K144N versus vector-transduced cells (Figs. 3C and D) . To determine whether the accelerated production of rRNA equated with increased protein synthesis, cytosolic fractions were collected for ribosome profile analysis. Both Flag-DDX5 and Flag-DDX5-K144N enhanced the amplitude of the actively translating polyribosome fraction (Fig.   3E ), indicating that ectopic expression of Flag-DDX5 ultimately increases ribosome availability for translation, and that helicase activity is not required for this induction. These results indicate that DDX5 stimulates the production of functional ribosomes by increasing the total amount of mature rRNA. 
DDX5 stimulates proliferation in mouse embryonic fibroblasts
The ability of DDX5 to stimulate rRNA synthesis suggested that it might also be critical for growth and proliferation.
The enhanced ribosome biogenesis caused by DDX5 overexpression corresponds to an increased proliferative capacity as evidenced by the ability of Flag-DDX5 and Flag-DDX5-K144N to stimulate foci formation in wild-type MEFs (Fig. 4A ).
Furthermore, using two different shRNA constructs, we demonstrated that knockdown of DDX5 reduced proliferation of Arf -/-MEFs in a dose-dependent manner (Figs. 4B and C) . The dependency on DDX5 for unrestricted growth was not exclusive to Arf-/-MEFs, as foci formation in p53-/-MEFs was impaired by shRNAs targeting DDX5 (Fig S2A and B) . DDX5
has been linked to p53 function in several reports, either as a transcriptional co-activator (32), or as a partner of p53 in microRNA processing (33) . While these relationships suggest that DDX5
could inhibit growth through its interactions with p53, our data point to the opposite conclusion, specifically that the dominant role of DDX5 is not growth inhibition as would be inferred from the aforementioned studies, but rather growth stimulation.
Knockdown of DDX5 phenocopies the p53-independent functions of ARF on ribosome output DDX5 stimulates ribosome production, whereas ARF inhibits ribosome biogenesis at several stages: 47S transcription, rRNA processing, and rRNA export (10, 28, 34) . Ultimately, the effects of Arf loss are exhibited by the enhanced ribosome profiles of Arf-/-MEFs relative to wild-type MEFs (10). It was unclear, however, whether these effects of ARF on the cellular ribosome profile were truly p53-independent. To characterize the p53-independent functions of ARF on ribosome biogenesis, we utilized TKO (p53-/-; Mdm2-/-; Arf -/-) MEFs, in which the entire ARF-Mdm2-p53 axis has been removed (9) . By adding ARF back into TKO MEFs we investigated growth-inhibitory effects of ARF that are completely independent of p53. HA-ARF expression reduced cytosolic ribosomes, most notably in the actively translating polyribosome fraction (Fig. 5A) , demonstrating a p53-independent role for ARF in the regulation of ribosome output. Knockdown of DDX5 in TKO MEFs mimicked the effects of ARF overexpression on cytosolic ribosome content (Fig. 5B) , causing a notable decrease in polyribosome peak amplitude. Thus, a DDX5 loss-of-function is equivalent to a p53-independent ARF gain-offunction on ribosome output.
ARF inhibits the interaction between DDX5 and NPM
We previously identified an interaction between NPM and DDX5 while probing for NPM binding partners (25) . Like DDX5, NPM is a multifunctional protein with key roles at multiple stages of ribosome biogenesis. NPM associates with the rDNA locus (35), regulating transcription and processing of the rRNA (11) . Further, NPM functions as a nuclear export chaperone for ribosomes (25) , a function that is antagonized by ARF (14) . Interestingly, early embryonic lethality is a phenotype of both Npm1-/-and Ddx5-/-mice (12, 30, 36) . We hypothesized that ARF impaired DDX5 function through regulation of its interaction with NPM.
Given the ability of ARF to regulate both proteins individually, we tested whether ARF effected the interaction between DDX5 and NPM. Comparison of WT and Arf-/-MEF lysates by co-immunoprecipitation revealed that ARF significantly reduced the interaction of DDX5 with NPM (Fig. 6A) . We then sought to determine the NPM-binding domain on DDX5 to assess whether this interaction was critical for the growth-stimulatory abilities of DDX5. Little has been reported on the proteins that interact with DDX5 through its C-terminal domain. Given the possibility that core domain mutations might directly impair conserved features that are critical CAN-11-1472 in the DEAD-box helicase family and complicate any interpretations of its overall importance, we instead focused on mutations in the C-terminus. A panel of overlapping C-terminal deletion mutations was introduced to DDX5 in a GST-fusion protein expression vector. In vitro immunoprecipitation reactions using His-tagged NPM and GST-DDX5 or its mutants mapped an NPM interaction motif to residues 500-610 at the C-terminus of DDX5 (Fig. 6B) . For further experiments, we chose a smaller mutant within this domain, DDX5ǻ520-550. While ectopically expressed Flag-DDX5 interacted with endogenous NPM in Arf-/-MEFs, the ǻ520-550 mutant displayed no visible interaction (Fig. 6C) . Flag-DDX5-ǻ520-550 also had reduced occupancy of the rDNA promoter compared to wild-type Flag-DDX5 (Fig. 6D) , and did not stimulate 47S prerRNA transcription (Fig. 6E) . Further, while Flag-DDX5 associated with nuclear pre-ribosomal fractions containing the 40S and 60S ribosomal subunits, Flag-DDX5-ǻ520-550 was almost completely absent from the 60S fractions containing the large ribosomal protein rpL7a (Fig. 6F) .
Finally, in transduced Arf-/-MEFs, Flag-DDX5-ǻ520-550 expression did not affect proliferation compared to the empty vector control, whereas Flag-DDX5 expression enhanced proliferation (Fig. 6G) . Thus, it appears that DDX5 cooperates with NPM, through a direct interaction that is antagonized by ARF, to stimulate rRNA synthesis and proliferation.
RasV12-induced transformation of Arf-/-MEFs requires DDX5
Transduction of wild-type MEFs with oncogenic RasV12 results in ARF induction and growth arrest (21) . Conversely, transduction of RasV12 transforms Arf-/-MEFs, as determined by colony formation in soft agar. To determine whether DDX5 meets the criteria of a classic oncogene, wild-type MEFs expressing Flag-DDX5 alone or in combination with RasV12, were plated in soft agar to evaluate anchorage-independent growth. While RasV12-transduced Arf-/- Fig. S3A ). Further, unlike RasV12, Flag-DDX5 was unable to stimulate transformation of TKO MEFs (Supplementary Fig. S3B ). This suggests that DDX5 is not an oncogene, as it cannot, in combination with Arf loss and p53 loss, or RasV12 overexpression, drive transformation.
Despite not being sufficient to transform cells, it remained possible that DDX5 was necessary for transformation. To determine whether DDX5 is required for oncogenic transformation in the absence of Arf, we transduced Arf-/-MEFs with shRNA against DDX5 followed by ectopic expression of RasV12 (Fig. 7A) . Knockdown of DDX5 impaired the ability of RasV12 to stimulate colony formation and anchorage-independent growth ( 
Discussion
The role of ARF in regulating p53 is well established, but the mechanisms by which it exerts its p53-independent tumor suppressor function have yet to be fully characterized. Our group and others have recently demonstrated the regulation of translation by ARF, but mechanistic details of its involvement are limited. Both mouse and human ARF interact with nucleolar proteins involved in ribosome biogenesis as well as ribosomal components themselves (11, 37) . Furthermore, ectopic expression of human p14ARF decreases polyribosomes in a p53-independent manner (37) . ARF has recently been linked to ribosome biogenesis through its regulation of TTF1 (28) and its ability to inhibit ribosome export via its nucleolar interaction with NPM (14, 38) . Here we have shown that ARF can control the protein composition of the nucleolus, the central organelle in ribosome biogenesis. Our observation that ARF can regulate DDX5 RNA helicase, provides a mechanistic explanation for the inhibitory effects of ARF on 47S rRNA transcription and processing (34) .
Our data suggest that most of the endogenous pool of DDX5 may be excluded from nucleoli and inactive in ribosome biogenesis until a cellular perturbation stimulates this activity. Consistent with this model, upon loss of Arf a substantial increase in nucleolar DDX5 was observed, accompanied by tremendous gains in ribosome production. Surprisingly, both DDX5 and the helicase-dead DDX5 mutant (K144N) were able to stimulate 47S transcription and cellular ribosome output. The ability of DDX5-K144N to increase 47S pre-rRNA transcription is consistent with reports that helicase activity may be dispensable for the activities of DDX5 as a transcriptional co-regulator (32, 39) . NPM was important for DDX5 to associate with the rDNA promoter and to facilitate 47S pre-rRNA transcription. The DDX5 NPM-binding mutant CAN-11-1472 was also unable to associate with the nuclear 60S pre-ribosomal fraction or enhance proliferation, further underscoring the link between the effects of DDX5 on ribosome biogenesis with those on growth and proliferation. Clearly, the formation of DDX5-NPM complexes, enhanced in the absence of Arf, is necessary for the nucleolar gain-of-function activity reported here for DDX5.
Our results provide a new perspective for understanding the tumor suppressor function of ARF, which has classically been thought of as a checkpoint sensor of hyperproliferative signals.
The data presented here suggest that an equally important mechanism by which ARF functions as a tumor suppressor is to limit ribosome output as a defense against oncogene activation and the attendant enhanced cellular protein requirements. Therefore, in the absence of Arf, DDX5 becomes a requisite non-oncogene effector that promotes an increased translational output in accord with the higher demand for protein production required upon oncogene activation. The cellular process, such as ribosome biogenesis, more efficient or prolific in preparation for the tremendous protein synthesis demands following malignant transformation. It remains to be determined whether DDX5 will be an efficacious target in the treatment of cancer; however our results validate its importance in supplying the sustained ribosome output required for oncogenic transformation. In summary, DDX5 participation in ribosome biogenesis is negatively regulated by ARF, which inhibits the DDX5-NPM interaction, suggesting a dynamic interplay through which ARF and DDX5 duel for nucleolar growth control. 
